Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE rejects Pfizer’s first-in-class breast cancer drug

February 3, 2017
Medical Communications, Sales and Marketing NICE, Pfizer, breast cancer

NICE has published draft guidelines which reject Pfizer’s Ibrance (palbociclib) based primarily on the cost of the drug but also …

News

Cirrus ready for serialisation pack changes

February 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cirrus, Multi Packaging Solutions

Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending …

News
Press release
heart_rope

More at risk of sudden death due to faulty heart gene than thought

February 2, 2017
Medical Communications, Research and Development British Heart Foundation, faulty gene, sudden death

The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …

News
insider_interview_headshots_2016_overview

2016: A retrospective from the industry

February 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

2016 was characterised by some of the biggest political shifts in recent times. We ask four major pharma figures for …

Feature

Pakistan drug regulatory body “a complete failure” according to officials

February 2, 2017
Sales and Marketing Drug Regulatory Authority of Pakistan, Pakistan, Sania Nishtar

Key figures in the Pakistani pharmaceutical industry are calling for review of the Drug Regulatory Authority of Pakistan (DRAP) over …

News
syringe-1973129_960_720

‘Last-resort’ antibiotic-resistant bacteria found along 4km of Chinese coastline

February 2, 2017
Medical Communications, Research and Development

Recent research has been published that reveals that a four kilometre stretch of coastline in China harboured bacteria resistant to …

News
allerganlogo

Allergan successfully completes $2.9bn LifeCell acquisition

February 2, 2017
Business Services, Sales and Marketing Allergan, LifeCell

The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …

News

Two-decade-long prostate cancer study finds antiandrogen improves survival

February 2, 2017
Research and Development antiandrogen, oncology, prostate cancer

Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …

News
rick_fair

Genentech oncology head leaves for Bellicum CEO role

February 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq

Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …

Appointment
msd_merck_night_building

MSD’s drug given European approval for first-line treatment in NSCLC

February 1, 2017
Sales and Marketing European Commission, MSD, Merck

The good news keeps coming for MSD, known as Merck in North America, and Keytruda, with a further label expansion …

News

Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection

February 1, 2017
Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab

Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …

News
pills_spill

Potential treatment for opioid withdrawal discovered

February 1, 2017
Medical Communications, Research and Development University of Calgary, gout, opioid

Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …

News
fda2outsideweb

Italian firm warned by FDA over record-shredding and drug quality misrepresentation

February 1, 2017
Manufacturing and Production, Research and Development FACTA Farmaceutici, FDA

Italian drug manufacturer FACTA Farmaceutici has been issued a warning letter by the FDA after being found shredding “critical laboratory …

News
immunisation

African Heads of State commit to universal access to immunisation

February 1, 2017
Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation

The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …

News
donald_trump_september_3_2015

Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices

January 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump

President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …

News
mylan_plus_hero_720x510_1

Antitrust investigation into Mylan begins over EpiPen

January 31, 2017
Research and Development, Sales and Marketing Mylan, pricing

The Federal Trade Commission has submitted a request to Mylan for information as part of a preliminary investigation into whether …

News
anopheles_albimanus_mosquito_web

First-line malaria treatment fails for the first time in UK

January 31, 2017
Manufacturing and Production, Research and Development UK, malaria

The key combination malaria therapy artemether-lumefantrine has failed to treat UK patients for the first time, suggesting that the parasite …

News
insulin-syringe-1972843_960_720

Price-fixing class action lawsuit levelled at three major insulin producers

January 31, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing

A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …

News

Trump’s “one in, two out” regulatory order threatens FDA, Obama Cures Act

January 31, 2017
Manufacturing and Production, Sales and Marketing FDA, Trump

An executive order signed by President Donald Trump on Monday has caused concern in the US pharma industry and beyond …

News
teva_copy

Teva hit by patent blow upon top-selling MS drug

January 31, 2017
Manufacturing and Production Mylan, Teva, generic, multiple sclerosis

Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026